How Delhi Derma Clinic works

Entry is through the dermatologist consultation, scheduled by prior appointment. The framework does not begin treatment from website-self-selection or from a quiz funnel; the consultation visit is the routing point. Patients enquiring about a specific concern are routed to the consultation rather than to a procedural pathway sold from the booking conversation.

At the booking stage the conversation establishes whether an in-person consultation or a video consultation fits the case best. Most first visits are in-person because examination findings drive recommendation. Video format applies in selected initial-orientation contexts for distance-restricted patients and for follow-up review where in-person examination is not necessary.

Patient-information collection at the booking and the arrival stage covers the orientation layer — presenting concern, prior history, current medications. The dermatologist then conducts the calibrated assessment in the consultation itself. The framework treats assessment as the dermatologist's clinical work rather than as a triage script handled by non-medical staff before the visit.

Operational details around payment timing are confirmed at the booking conversation. The framework treats the consultation fee as the cost of the visit itself, payable per the standard practice the clinic operates. The figure is stated transparently at the booking; there are no hidden fees layered on at the visit stage.

The consultation runs a structured-but-conversational pattern: history-taking on the presenting concern, examination of the relevant area, photographic baseline establishment where the pathway warrants it, blood-work request where systemic context is suggested, and the calibrated written plan handed over at the close. A clinical conversation is what the visit is structured as — not a sales appointment.

Dr Chetna Ghura, MBBS MD Dermatology, DMC 2851 is the dermatologist and clinical decision-maker for assessment and recommendation. Selected procedural protocols are operated by trained clinical-team members under the dermatologist's supervision, but the assessment and the recommendation are dermatologist-led. The clinical approach page covers the standards layer.

Visit length is calibrated to the case rather than fixed at a clock-driven slot. A typical first-visit consultation runs around thirty-to-forty-five minutes; complex multi-concern cases run longer. The framework does not run consultation as an aggressively-paced funnel; thoroughness is part of how the recommendation is arrived at well rather than as optional polish.

Complex cases — multi-concern presentations, prior-treatment-failure histories, systemic-medical-context overlays — are handled within the same consultation framework with extended visit-time and appropriate referral where needed. The framework collaborates with internal-medicine, gynaecology, surgical referral, and other specialties where the case warrants their input rather than absorbing decisions outside dermatology scope.

The consultation conversation is where disagreement gets surfaced and worked through. The framework respects patient autonomy without abandoning clinical responsibility — selected requests cannot be honoured because they fall outside what is clinically defensible, and that boundary is communicated rather than worked around. Where the patient has a different view of the right pathway, the conversation surfaces the rationale on both sides.

The written plan covers: the calibrated recommendation, the rationale connecting the assessment to the recommendation, the realistic outcome range across an evidence-based time window, the maintenance pattern where applicable, the residual-risk profile, the per-component pricing for the recommended pathway, the proposed follow-up cadence, and any blood-work or referral information. The plan is the patient's document for the case.

No. The plan is a calibrated recommendation rather than a contract. The patient retains the decision about whether and when to act on the plan. The framework does not require the patient to commit to the plan at the consultation; consideration time is part of how decisions are arrived at well rather than rushed. Patients can return for follow-up, can defer the pathway, or can choose not to proceed.

The per-component pricing for the recommended pathway is embedded in the written plan rather than displayed on the website as a generic list. The reason is that procedural pricing depends on factors that only the consultation can calibrate — case context, realistic session count, device selection, maintenance pattern. The Pricing FAQs covers the framework.

The plan is the patient's document. Sharing with another medical practitioner for second opinion or for a coordinated-care context is supported. The framework treats records as patient-supportive rather than as proprietary clinic information.

Plan revision is part of the framework. Calibration changes that affect cost or pathway structure — early-response review suggesting a different approach, the patient's context changing, an unexpected response pattern — are surfaced and a revised plan is produced rather than the original plan being held to as a sunk-cost commitment. The follow-up review cadence is the natural touch-point for revision conversations.

For most cases the consultation ends with the written plan and procedural work begins at a subsequent visit after the patient has had time to consider the plan. For straightforward cases where the suitability assessment supports it, calibrated procedural work can begin on the consultation day itself. The framework does not pressure the same-day path; it depends on what fits the case clinically and what fits the patient's decision pace.

A procedural visit follows its own structured pattern: pre-procedure preparation review, informed consent for the specific procedure (covering procedure, expected experience, residual risk, alternatives, post-procedure expectations), the calibrated procedural work itself, and post-procedure care instructions. The framework treats informed consent as substantive rather than as a paperwork hurdle; questions are welcomed at the consent stage.

Multi-session pathways — laser-hair-reduction, selected pigmentation pathways, structured chemical peel courses, body-contouring multi-session series, hair-restoration medical pathways with periodic procedural touch-points — are calibrated at the plan stage and managed across the active course. Each session follows its own consent and post-care framework, with structured progress review at the relevant intervals.

Post-procedure follow-up is calibrated to the pathway and the procedure. Selected procedures include a short post-procedure check at the day-one or week-one window for safety review; selected procedures rely on the response window — typically three-to-six months — as the meaningful review point. The post-procedure care instructions cover the patient-side care during the in-between window.

The framework includes residual-risk discussion as part of pre-procedure consent, and post-procedure care instructions include the trigger-points for the patient to contact the clinic if anything unexpected develops. Where a post-procedure issue requires clinician review the patient is seen in the relevant urgency window. The framework does not treat residual-risk events as forbidden topics; it discusses them transparently up front and handles them clinically when they occur.

Follow-up cadence is calibrated to the pathway. Active procedural pathways are typically reviewed at the relevant response window. Hair-loss, pigmentation, and ageing-trajectory maintenance pathways run on a six-monthly through annual review pattern. Selected medical-dermatology pathways have their own pattern. The framework treats follow-up as part of the care continuum rather than as the end of a project.

Maintenance varies by pathway. For hair-loss pathways, maintenance is usually structured pharmacologic continuation with periodic review; for pigmentation, maintenance is often topical-and-lifestyle continuity with selected periodic procedural touch-points; for ageing-trajectory, maintenance is selected periodic touch-ups with structured continuity-of-care. The maintenance pattern for any specific case is part of the original written plan.

Yes, in selected contexts — maintenance reviews where in-person examination is not necessary, prescription continuity review where the regulatory framework supports it, and selected coordination touch-points. The Teleconsultation Policy in the policies section is the formal source for the operational mechanics around video visits.

The framework does not lock the patient into the pathway. Patients who choose to pause or stop maintenance can return at a later point with a fresh assessment of the trajectory at that time. The framework treats discontinuation as the patient's decision rather than as a failure-to-comply issue.

Many pathways do not formally "close" — the maintenance pattern continues at the calibrated cadence. For procedural courses with a defined endpoint (selected scar-resurfacing courses, selected laser-hair-reduction zones with the realistic endpoint reached) the formal closure is communicated, with a maintenance pathway suggestion where applicable.